Highlights Pila Pharma AB

Equities

PILA

SE0015988274

Market Closed - Nasdaq Stockholm Other stock markets 08:49:42 31/05/2024 pm IST			5-day change	1st Jan Change
3.1 ^SEK	+2.99%		+10.71%	+93.75%

19/04	Pila Pharma Appoints New CEO, Chief Scientific Officer	MT
19/04	Pila Pharma AB Announces Board and Management Appointments	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pila Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02	CI
Pila Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Pila Pharma Enters Research Collaboration to Study Heart Disease Treatment in Mice	27/11	MT
Pila Pharma AB Enters Research Collaboration with the Research Group of Professor Dick Wagsater, Uppsala University, Sweden	27/11	CI
Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	25/23/25	CI
Pila Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23/23/23	CI
Pila Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Pila Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	01/23/01	CI
Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	26/22/26	CI
Pila Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/22/26	CI
Pila Pharma AB Announces the Preclinical Toxicological Three-Month Studies of the Active Substance Xen-D0501 Has Begun	30/22/30	CI
Pila Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Pila Pharma AB Announces Certification of API	25/22/25	CI
BioStock: Pila Pharma's CEO on building the company since its IPO	25/22/25	AQ
Pila Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	18/22/18	CI
BioStock: Pila Pharma takes final steps before toxicology studies	22/21/22	AQ
PILA PHARMA AB has completed an IPO in the amount of SEK 34.999992 million.	12/21/12	CI
PILA PHARMA AB has filed an IPO in the amount of SEK 34.999992 million.	15/21/15	CI
PILA PHARMA AB acquired TRPV1 antagonists from Ario Pharma Limited.	30/16/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer